Related Experiment Video

Updated: Aug 24, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Tacrolimus ointment in the treatment of eyelid dermatitis

Amy Krupnick Freeman1, Janet Serle, Paul VanVeldhuisen

  • 1Department of Dermatology, Mount Sinai School of Medicine, New York, New York, USA. amykfreeman@hotmail.com

Cutis
|May 12, 2004
PubMed

Insights

Tacrolimus ointment 0.1% effectively treated moderate to severe eyelid atopic dermatitis in a clinical trial. Most patients showed significant improvement with minimal side effects like burning or itching, and no adverse eye pressure changes.

Area of Science:

  • Dermatology
  • Ophthalmology
  • Immunology

Background:

  • Atopic dermatitis (AD) commonly affects the eyelids, causing significant discomfort and visual impairment.
  • Current treatments for eyelid AD may have limited efficacy or undesirable side effects.
  • Tacrolimus ointment is a topical calcineurin inhibitor used for AD but its use on eyelids requires further investigation.

Purpose of the Study:

  • To assess the safety and efficacy of tacrolimus ointment 0.1% for treating moderate to severe atopic dermatitis of the eyelids.
  • To evaluate the impact of tacrolimus ointment on ocular health, including intraocular pressure, cataract, and glaucoma development.

Main Methods:

  • An open-label clinical trial involving 21 patients with moderate to severe eyelid dermatitis.
  • Patients applied tacrolimus ointment 0.1% twice daily for 8 weeks, with a 2-week follow-up post-treatment.
  • Efficacy was measured by investigator assessment of dermatitis signs/symptoms and Physician Global Assessment (PGA); complete eye examinations were performed.

Main Results:

  • Significant improvement in eyelid dermatitis signs and symptoms was observed.
  • 80% of patients (16/20) achieved marked improvement or better based on PGA at 8 weeks.
  • Adverse events were transient local burning (60%) and itching (25%); no statistically significant increase in intraocular pressure, cataracts, or glaucoma was noted.

Conclusions:

  • Tacrolimus ointment 0.1% appears to be a safe and effective treatment for moderate to severe eyelid atopic dermatitis.
  • The study supports the use of tacrolimus ointment for eyelid dermatitis, with a favorable safety profile regarding ocular health.
  • Further research may confirm these findings and establish optimal treatment protocols for eyelid AD with topical calcineurin inhibitors.

Related Concept Videos

Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...